A prospective, randomized, double-blind, placebo-controlled trial for the primary prevention of blood clots in adult patients with active cancer who are scheduled to receive therapy to control, slow or eradicate the cancer, such as chemotherapy, in the outpatient setting

Trial Profile

A prospective, randomized, double-blind, placebo-controlled trial for the primary prevention of blood clots in adult patients with active cancer who are scheduled to receive therapy to control, slow or eradicate the cancer, such as chemotherapy, in the outpatient setting

Planning
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2015

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Cancer; Venous thromboembolism
  • Focus Therapeutic Use
  • Acronyms CALLISTO
  • Most Recent Events

    • 02 Jun 2015 New trial record
    • 28 May 2015 This study is a part of CALLISTO clinical research program. This program consists of seven clinical studies and two observational registries.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top